Democratizing cancer diagnostics for better patient outcomes

Rarity Biosciences’ vision is to democratize cancer diagnostics by providing more accessible, patient-near laboratory analysis – based on a simple blood sample. An ultrasensitive liquid biopsy assay that can be analysed for all relevant mutations along with other blood works on existing instruments, in a laboratory near the practicing clinician.

Contact usFollow us on LinkedIn